TY - JOUR
T1 - Childhood nail psoriasis
T2 - A useful treatment with tazarotene 0.05%
AU - Diluvio, Laura
AU - Campione, Elena
AU - Paternò, Evelin J.
AU - Mordenti, Cristina
AU - Hachem, Maya El
AU - Chimenti, Sergio
PY - 2007/5
Y1 - 2007/5
N2 - Nail psoriasis occurs in 7% to 40% of children, with a similar pattern of clinical presentation to that of adults. In 0.6% to 2.3% of the patients nail changes appear as the only sign of the disease, preceding other skin and articular involvement. No pediatric clinical trials are available yet, but considering the successful use of tazarotene for nail dystrophy therapy in adults, we chose this drug to treat a child.
AB - Nail psoriasis occurs in 7% to 40% of children, with a similar pattern of clinical presentation to that of adults. In 0.6% to 2.3% of the patients nail changes appear as the only sign of the disease, preceding other skin and articular involvement. No pediatric clinical trials are available yet, but considering the successful use of tazarotene for nail dystrophy therapy in adults, we chose this drug to treat a child.
UR - http://www.scopus.com/inward/record.url?scp=34249779263&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34249779263&partnerID=8YFLogxK
U2 - 10.1111/j.1525-1470.2007.00421.x
DO - 10.1111/j.1525-1470.2007.00421.x
M3 - Article
C2 - 17542899
AN - SCOPUS:34249779263
VL - 24
SP - 332
EP - 333
JO - Pediatric Dermatology
JF - Pediatric Dermatology
SN - 0736-8046
IS - 3
ER -